Chronic Obstructive Pulmonary Disease, Heart Failure
Conditions
Keywords
Chronic diseases, Aging people, Cross-border care, New communication technology
Brief summary
Chronic diseases are frequent (around 10% of the total population and 30% after 60 years) and accelerate age-related functional decline. Concerning cross-border patients, use of health services can be delayed given the distances, the lack of rapid road access and the limited availability of public transport and the complex organization of coordinated care. One of the ways to reduce acute exacerbations and preserve the quality of life of patients is to detect warning signs early. One of the ways to do this is to use new communication technologies.
Detailed description
The aim of the study is to assess feasibility of using a connected tablet to assess clinical parameters with an alert system in frailty patients aged over 60, living at home, with heart failure and / or chronic obstructive pulmonary disease, potentially requiring care cross-border (France and Belgium).
Interventions
OTHERData collection
Daily record of temperature, weight, heart rate, systolic blood pressure and oxygen saturation
Sponsors
Université de Reims Champagne-Ardenne
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients aged over 60 * Patients living at home * Patients with heart failure and / or chronic obstructive pulmonary disease, * Patients potentially requiring care cross-border (France and Belgium). * Patients agreeing to participate to the study
Exclusion criteria
* Patients who do not speak French * Patients with severe cognitive impairment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Alert according to the connected tablet | 12 months | significant change in temperature (egal or more 38°), weight (variation of more than 5%), heart rate (less than 50 beats per minute or greater than 100), systolic blood pressure (less than 85 mmHg or greater than 160 mmHg) and / or oxygen saturation (variation of more than 4%) |
Countries
France
Contacts
Primary ContactJean-Luc NOVELLA
Outcome results
None listed